Anti-arrhythmic effects of statins: A hypothesis remains to be tested

Heart Rhythm

Volumn 5, Issue 4, 2008, Pages 511-512

  Guo, Hongsheng M ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIARRHYTHMIC ACTIVITY; CARDIOMYOPATHY; CLINICAL TRIAL; DEFIBRILLATOR; DRUG FATALITY; DRUG MONITORING; DRUG USE; EDITORIAL; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUDDEN DEATH; TEACHING HOSPITAL;

ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL ISCHEMIA; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 40849116122     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.01.033     Document Type: Editorial

References (14)

1. Wei H., and Shu Z. Epidemiology study on incidence of sudden cardiac death in China (2007), Personal communication, Fuwai Hospital, Beijing
2. Spooner P.M., and Zipes D.P. Sudden death predictors: an inflammatory association. Circulation 105 (2002) 2574-2576
3. Huikuri H.V., Mäkikallio T.H., Raatikainen M.J., et al. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108 (2003) 110-1115
4. Coleman C.I., et al. Association Between Statin Use and Mortality in Patients with Implantable Cardioverter Defibrillators and Left Ventricular Systolic Dysfunction. Heart Rhythm (2008) 507-510
5. De Sutter J., Tavernier R., De Buyzere M., et al. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 36 (2000) 766-772
6. Mitchell L.B., Powell J.L., Gillis A.M., et al., AVID Investigators. Are lipid-lowering drugs also antiarrhythmic drugs?. An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 42 (2003) 81-87 Jul 2
7. Vyas A.K., Guo H., Moss A.J., et al., MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 769-773
8. Chiu J.H., Abdelhadi R.H., Chung M.K., et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol 95 (2005) 490-491
9. Dickinson M.G., Ip J.H., Olshansky B., et al., SCD-HeFT Investigators. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 153 (2007) 573
10. Goldberger J.J., Subacius H., Schaechter A., et al., DEFINITE Investigators. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1228-1233
11. Albert C.M., Ma J., Rifai N., et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2574-2576
12. Plenge J.K., Hernandez T.L., Weil K.M., et al. Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction. Circulation 106 (2002) 1447-1452
13. Koh K.K., Schenke W.H., Waclawiw M.A., et al. 3rd Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women. Circulation 105 (2002) 1531-1533
14. Albert M.A., Danielson E., Rifai N., et al. Effect of statin therapy on Creactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70